Novo

Novo Nordisk shares jump almost 8% after US approves Wegovy pill
Novo Nordisk shares jump almost 8% after US approves Wegovy pill
The approval gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine [COPENHAGEN/LONDON] Novo Nordisk shares jumped nearly 8 per cent on Tuesday (Dec...
Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring
Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring
[COPENHAGEN] Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5 per cent of its workforce, in a restructuring to save eight billion Danish crowns (S$1.6 billion) annually, it...
Novo Nordisk overtakes SAP as Europe’s most valuable company
Novo Nordisk overtakes SAP as Europe’s most valuable company
Published Fri, Jun 13, 2025 · 05:38 PM[COPENHAGEN] Novo Nordisk reclaimed its position as Europe’s most valuable public company, overtaking software developer SAP. Shares in the Danish drugmaker climbed as...
Novo Nordisk overtakes SAP as Europe’s most valuable company
Novo Nordisk latest drugmaker to drop gender goals in US
This follows executive orders by President Donald Trump to stop diversity, equity and inclusion initiativesPublished Wed, May 7, 2025 · 06:55 PM[COPENHAGEN] Obesity drugmaker Novo Nordisk said on Wednesday...
Novo seeks US0 million from Singapore firm, accusing it of fraud over drug
Novo seeks US$830 million from Singapore firm, accusing it of fraud over drug
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying it was misled by a local biotech about the effectiveness of an experimental...
Novo seeks US0 million from Singapore firm, accusing it of fraud over drug
Singaporean Huang Zhenhua’s assets frozen over US$830 million suit by drug giant Novo
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying that it was misled by a local biotech firm about the effectiveness of...
Novo seeks US0 million from Singapore firm, accusing it of fraud over drug
Singapore court freezes worldwide assets in US$830 million Novo Nordisk suit
The Danish drugmaker alleges misrepresentations by biotech firm founder Huang Zhenhua about the success of its kidney drug PHARMA giant Novo Nordisk has been granted an injunction by the...
Europe: Stoxx 600 inches up as Novo Nordisk surges at start of Christmas week
Europe: Stoxx 600 inches up as Novo Nordisk surges at start of Christmas week
EUROPE’S Stoxx 600 closed slightly higher at the start of a holiday-shortened week, as a spike in Novo Nordisk shares boosted the healthcare sector and capped losses on the...